Merck & Co., Inc. (6MK.DE) Stock Overview
Explore Merck & Co., Inc.’s financial performance, market position, analyst ratings, and future outlook.
Merck & Co., Inc. (6MK.DE)
Key Financials
Key Financials
Market Cap
290.3B
P/E Ratio
106.33
EPS (TTM)
$2.50
ROE
0.07%
6MK.DE Stock Analysis & Investment Overview (XETRA)
Our AI-powered analysis of Merck & Co., Inc. (XETRA: 6MK.DE) gives investors deep insight into how the stock performs on the XETRA exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Merck & Co., Inc.'s XETRA-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of 6MK.DE on the XETRA shows an RSI of 62.57, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $93.07 for the XETRA listing.
Key metrics behind Merck & Co., Inc.'s XETRA-traded stock include a P/E ratio of 106.33 and a market capitalization of 290.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of 6MK.DE on the XETRA.